Effects of a vildagliptin/metformin combination on markers of atherosclerosis, thrombosis, and inflammation in diabetic patients with coronary artery disease

Saxagliptin for the treatment of type 2 diabetes mellitus: assessing cardiovascular data

(2012) Michael E Cobble et al.   Cardiovascular Diabetology

Cardiovascular safety with linagliptin in patients with type 2 diabetes mellitus: a pre-specified, prospective, and adjudicated meta-analysis of a phase 3 programme

(2012) Odd Johansen et al.   Cardiovascular Diabetology

FDA rejects novel diabetes drug over safety fears

(2012) Talha Khan Burki   LANCET

Plasma total and high molecular weight adiponectin levels and risk of coronary heart disease in women

(2011) Tobias Pischon et al.   ATHEROSCLEROSIS

Early and late effects of the DPP-4 inhibitor vildagliptin in a rat model of post-myocardial infarction heart failure

(2011) Meimei Yin et al.   Cardiovascular Diabetology

Diabetes and Antiplatelet Therapy in Acute Coronary Syndrome

(2011) José Luis Ferreiro et al.   CIRCULATION

Long-Term Dipeptidyl-Peptidase 4 Inhibition Reduces Atherosclerosis and Inflammation via Effects on Monocyte Recruitment and Chemotaxis

(2011) Zubair Shah et al.   CIRCULATION

Platelet indices in diabetes mellitus: indicators of diabetic microvascular complications

(2011) Sonali Jindal et al.   Hematology

Protective role of adiponectin on endothelial dysfunction induced by AGEs: A clinical and experimental approach

(2011) Serena Del Turco et al.   MICROVASCULAR RESEARCH

Antidiabetic treatments and risk of hospitalisation with myocardial infarction: a nationwide case-control study

(2011) Henriette Thisted Horsdal et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

Increased levels of platelet activation markers are positively associated with carotid wall thickness and other atherosclerotic risk factors in obese patients

(2011) Bela Nagy et al.   THROMBOSIS AND HAEMOSTASIS

Hypoglycaemia-induced myocardial infarction as a result of sulphonylurea misuse

(2010) B. T. Corley et al.   DIABETIC MEDICINE

Vildagliptin

(2010) Gillian M. Keating   DRUGS

Effects of One Year Treatment of Vildagliptin Added to Pioglitazone or Glimepiride in Poorly Controlled Type 2 Diabetic Patients

(2010) G. Derosa et al.   HORMONE AND METABOLIC RESEARCH

Severe Hypoglycemia and Risks of Vascular Events and Death

(2010) Sophia Zoungas et al.   NEW ENGLAND JOURNAL OF MEDICINE

Associations of inflammatory markers with coronary artery calcification: Results from the Multi-Ethnic Study of Atherosclerosis

(2009) Nancy Swords Jenny et al.   ATHEROSCLEROSIS

Factors Contributing to Increased Platelet Reactivity in People With Diabetes

(2009) D. J. Schneider   DIABETES CARE

Metalloproteases 2 and 9, Lp-PLA2 and Lipoprotein Profile in Coronary Patients

(2008) Maria Luz Muzzio et al.   ARCHIVES OF MEDICAL RESEARCH

Matrix metalloproteinases and inflammatory markers in coronary artery ectasia: their relationship to severity of coronary artery ectasia

(2008) Abdullah Dogan et al.   CORONARY ARTERY DISEASE

Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein

(2008) Paul M Ridker et al.   NEW ENGLAND JOURNAL OF MEDICINE